PsyIndex Weekly Update

August 17, 2020 – August 21, 2020

The PsyIndex fell 5.37% last week as traders continued to take profits, adding to the prior week’s losses. This week, the index continued to trend lower despite news that MAPS raised $30 million from tech executives and others to make MDMA a legal treatment for post-traumatic stress disorder.

 

Top Gainers

Top Decliners

 

Corporate News, Deals & Listings

 

Previously Announced Upcoming Listings

  • Field Trip Psychedelics Inc. announced a letter of intent with Newton Energy Corporation (TSX.V: NTN.H). In addition, the company plans to complete a brokered private placement of common shares at a price of $2.00 per common share for gross proceeds of between $14 million and $15 million.
     
  • Silo Wellness Inc. announced a proposed reverse takeover with Yukoterre Resources Inc. (CSE: YT). In connection with the transaction, the company will complete a private placement for gross proceeds of approximately $2.5 million.
     
  • Entheon Biomedical Corp. announced a definitive amalgamation agreement with MPV Exploration Inc. to list on the CSE. In conjunction, it will complete a non-brokered private placement of subscription receipts to raise C$2 million in working capital.
     
  • Havn Life Sciences announced the launch and filing of its preliminary prospectus.
     
  • Novamind Ventures Inc. signed a letter of intent with Hinterland Metals Inc. and undertook a $3 million non-brokered private placement to go public on the Canadian Securities Exchange (CSE).
     
  • Mindset Pharma Inc. signed a letter of intent with North Sur Resources Inc. and aims to raise $1 million in a private placement to go public on the Canadian Securities Exchange (CSE).
     
  • Magical Brands Corp. updated its plans to list on the TSX Venture exchange through its three-cornered amalgamation with Good2Go Corp. (TSXV: GOTO.P).

 

Industry Developments

  • The Multidisciplinary Association for Psychedelic Studies, or MAPS, raised $30 million to fund a Phase III clinical trial on MDMA to treat post-traumatic stress disorder (PTSD). via Marijuana Moment
     
  • Rep. Joe Kennedy III, D-Mass., has not only changed his stance on marijuana in favor of legalization, but said psychedelics are a promising treatment option for PTSD. via StreetInsider

Cannabis Law Report Has Been Publishing Legal, Professional & Regulated
Cannabis News Daily Since 2016 – All For Free

We want to carry on providing the important cannabis sector
news for free for all our readers.

Costs are rising to produce Cannabis Law Report and we’d like to ask you,
our readers, for a small donation.


Primary Sponsor

Cannabis Banking - FinCann

New: Free USA Cannabis Case Law Search – New Cases Daily

Directory Categories

Karma Koala Podcast

Sponsor – aBizinaBox

Top Marijuana Blog
%d bloggers like this: